Gliknik is a privately held biopharmaceutical company working to ease human suffering by creating new therapies for people living with cancer and immune disorders.
[
]
Therapeutics
[
]
Therapeutics
Location: United States, Maryland, Baltimore
Total raised: $124.4M
Investors 4
| Date | Name | Website |
| - | Brace Phar... | bracepharm... |
| - | Takeda Ven... | takeda.com |
| 10.04.2022 | UM Venture... | umventures... |
| - | First In V... | firstinven... |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 27.06.2021 | Series C | $81M | - |
| 02.10.2013 | - | $25M | - |
| 01.05.2013 | - | $10M | - |
| 08.10.2012 | Series B | $4.9M | - |
| 06.01.2011 | - | $3.5M | - |
Mentions in press and media 18
| Date | Title | Description |
| 01.12.2021 | Baltimore, these are your nominees for the 2021 Technical.ly Awards | How did you move forward this year? As we move toward the latter stages of Q4 and the calendar turns to December, it’s a question that will start popping up more and more in the coming days. Part of the answer might lie in recognizing not o... |
| 28.06.2021 | How will Benchmark change with this new era of venture capital? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Looking for a competitive advantage? Heed the lessons of 2020 From Deloitte The pand... |
| 28.06.2021 | How will Benchmark change with this new era of venture capital? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Why today's marketers need strong collaboration tools From Optimizely The pandemic h... |
| 27.06.2021 | Gliknik Raises $11.5M in Series C Financing | Gliknik Inc., a Baltimore, MD-based immunology company dedicated to patients with cancer and autoimmune disorders, completed an $11.5m Series C financing. The round was led by First In Ventures (FIV) with participation from SAISO Partners a... |
| 25.06.2021 | An $11.5M Series C will help Gliknik advance 3 treatments for cancer, autoimmune disease | Add a company based in Baltimore’s University of Maryland BioPark to this week’s Money Moves. Gliknik, a company developing treatments for people with cancer and autoimmune diseases, announced completion of its Series C round. The company r... |
| 24.06.2021 | Gliknik Inc. : Raises $11.5 Million in Series C Financing | Gliknik Inc., an immunology company dedicated to patients with cancer and autoimmune disorders, today announced that it has successfully completed an $11.5 million Series C Preferred Stock financing. First In Ventures (FIV) led the Series C... |
| 19.02.2019 | Gliknik receives $15M payment from Pfizer after reaching clinical milestone | Baltimore biopharmaceutical startup Gliknik said human trials began for a candidate drug it’s developing to treat a rare neurological disorder. With the beginning of the Phase I clinical trial, the University of Maryland BioPark-based compa... |
| 09.01.2014 | 5 MD companies that received most venture funding in 2013 | Two Baltimore city companies are among the five Maryland companies that received the most venture capital in 2013. Advertising technology company Videology — based in Tide Point and founded by the brothers who founded Advertising.com — come... |
| 02.10.2013 | Biotech startup Gliknik lands $25M licensing deal with Pfizer [Startup Roundup] | Have news for the Startup Roundup? Get in touch.who’s getting funded? TNI Biotech, Inc., based in Bethesda, has raised $2.8 million in equity, according to SEC filings. The biotech company develops immunotherapy treatments for cancer and au... |
| 18.09.2013 | Gliknik in BioPark raises $2.8M in equity [Startup Roundup] | Have news for the Startup Roundup? Get in touch.who’s getting funded? Gliknik, based in the University of Maryland BioPark, has raised $2.8 million in equity, according to SEC filings. The biopharmaceuticals company creates “new therapies f... |
Show more